Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
While NASDAQ pending, last thing CVSI management wants to do is create "noise" and thus cause shorters paradise $9 to $3 hourly or overnight. I am sure such volatility of 200% would be counter-impressive to NASDAQ as far stock price stability is concerned.
Btw, you should analyze trades for past weeks. It seems a big entity working with MM is very slowly scooping shares. Amount of MM trades have increased significantly as percentage of oral volume.
Any gains on top of fair market price at the time of excercise will become capital gain vs ordinary income if cashless option excercise. Typical for management to excercise if expecting significant pps rise in near future. Shows confidence neurosurgeon putting his own money.
Does anyone think NASDAQ may delay decision beyond 90 day due CBD legality grey area while farm bill is pending or will deny expecting CVSI to resubmit later?
I concur. @BKK "Grown-up yet?"
From GWPH board regarding DEA rescheduling of CBD
The 90 days starts on the day that the FDA submits their approval paperwork, not from the day of the approval announcement (June 25).
Expect that the 90 day window actually closes this Thursday or Friday. Paperwork was submitted on around June 29th give or take a day.
Very well described!
Definitely good! The article is very professionally done and not an amateur job. Seems like Big players have taken positions. My feel is Wednesday will be very green. GLTA
I think there is a whale behind this article. Author/publisher seems to be well connected and charges hefty for the research/publishing services.
It's paid promotion for cii ..x. Careful.
In fact rescheduling of Epidiolex might hurt the CBD stocks. It may look like only Epidiolex strain is legal and all the other CBD strains are still scheduled 1 despite the fact that the CBD derived from hemp under 0.03 THC are ok as per 2014 farm bill
It might be just rescheduling of Epidiolex formulation and not CBD. t In that case, it will be a non-event. DEA may want to leave descheduling CBD for the farm bill.
CBD under 0.03 THC is anyway legal and immune from DEA enforcement, just too fragile to bank upon and needs Congress stamp via Hemp bill.
Worthless designation - Is there specific document that I need to provide to cpa to claim capital loss. Will appreciate help on this.
User acquisition cost is a very key observation. User brand awareness play very important role meteroic rise of a stock. Most of the stocks with products in the hands of the Investors and with direct impact on day-to-day lives tend to grow many folds. Microsoft, Apple, Netflix, Chipotle, tesla, Red Bull(monster) and so many more. None of the high flying Canadian MJ Co has created strong brands. In fact, Canada is not well known for producing brands in general. California alone is size of Canada market. Serious money is in the USA especially when coca cola talks CBD everyone listens. It will dwarf constellation move to canopy.
CVSI and cwe.b are the only USA public Co who have created strong national level CBD brands(Elixinol is Australian). CVSI has poliferated more stores at national level where as cwe.b grew more through online sales. CVSI product price point advantage coupled with outreach through brick and mortar stores is very important for 55+ consumers who are not very comfortable buying online when trying new health products. GRAS certification is another feather in their hat to attract national chain stores or potential acquirer.
To sum up, a national/international giant will be very comfortable paying huge premium for acquiring brand like PlusCBD but before that pps has to reach much higher level, co to serious funding through mixed secondary offering post NASDAQ before CVSI management considers acquisition. It is business miracle to be invested in space where large Giants are so restricted yet so ready to participate. Similar case study Hanson Naturals aka red bull aka Monster.
Sit tight on this one till middle of October.
@BKK can you provide your reasoning for being doubtful on uplisting other than sec settled case against Mona. Wouldn't that cause outright rejection instead of keeping application for over 7 weeks.
Could very well be - to ring the NASDAQ Market bell!!!
https://business.nasdaq.com/discover/market-bell-ceremonies/#?month=september&year=2018
As much as $14-17 sounds pretty good but I doubt we will see that before Q3 earning. I think Q3 revenue will be around 17-18 Million which would get the right eyes on this stock to push it 17+ or even 25 range
I personally feel that FDA CBD rescheduling and NASDAQ may come at the same time around Sept 21st, which would push CVSI 9+ in just two trading sessions.
Your analysis is pretty reasonable and logical but I read on another board that somehow this is interlinked with CWE%B listing on USA OTC which is scheduled for Oct 10th. Wall street behind the scenes. No idea.
Looking at TA and IC cloud, upmove begins this week crossing 6.50 by Thursday. NASDAQ will not happen until Oct 10th. It would gain quite a lot much before NASDAQ since Wall Street is usually weeks and months ahead. If on sidelines, don't wait too long waiting for actual NASDAQ listing since price will start to adjust upwards much before that.
*My personal opinion, not an advice.
@Mono Thoughts on latest price action on CVSI?
NASDAQ may happen around 9/23 about 8 weeks from filing datenor late October which would mean passing farm bill is the contingency.
This is partly true. It will bump the price a bit but real hemp mania and prolonged gold Rush will be enjoyed by select few tickers with real CBD products, strong fundamentals and revenue growths. Also as rule of thumb, OS of less than 100 million will get more attention than bloated SS. Unfortunately, SIPC is not one of those tickers. They haven't capitalized on CBD like others.
CBD is new revolution. Invest in companies with products on shelves. SIPC is far away from scalable revenue generating products. Invest wisely, not keep hoping for single catalyst without financials and fundamentals to support.
It seems while NASDAQ is pending, CVSI is treating this as quiet period and not issue any non-material news or statements. They are saving all that ammo for post uplisting. IMHO
CVSI more than doubles its CBD market share in a year from 5% to 11%.
From Forbes August 2017
https://www.cbdtesters.co/2018/09/12/the-us-cbd-market-will-reach-22-billion-by-2022/
Looking at the list of the top players in the US CBD market we can see that CW Hemp (12%) is still leading, followed by CV Sciences (Plus CBD Oil) with 11%, Medical Marijuana Inc. (Kannaway, HempMeds) with 10% and Green Roads with 6%. As predicted, the gap between larger and smaller companies has widened, with the top 20 making up to 66% of the total market.
If not stuck due to farm bill, it may come week of Sept 17th. If NASDAQ holding it up due to farm bill, expect third week of October just before next quarter results. IMHO
Pure salami hype, no financials, no revenue. Other CBD companies are making millions without waiting for farm bill. Invest in good companies making money in CBD space. Don't keep watching this one while whole new industry sweeps by you.
CV Sciences started FDA GRAS in 2014-15 and spent upwards of a million dollars to reach FDA GRAS status. This is serious money for so called stinky pinky company. Their closest competition could be years behind on this. It establishes them as industry leaders and visionaries with oncoming high visibility in media, political, regulators, and policy makers circle. We all know what that means.
Learn, project and benefit.
Once CBD goes mainstream, insurance companies may stop covering opioids based painkillers and include CBD based painkillers in prescription plans. This will be huge for PlusCBD, now that it's FDA GRAS with competition miles away.
There are many OTC stocks for trading only while CVSI could become generational stock. Learn and benefit.
FDA GRAS will enable PlusCBD to be picked up by mass retailers as Walmart, Walgreens etc. once farm bill goes through. CBD is not MJ, and PlusCBD is going to be Advil and Tylenol of new world of pain killers and replacing opioids at the same time. Learn the potential, position yourself even if in a small way.
"A 14-day repeated oral dose-range finding study conducted in Wistar rats at 1000, 2000, and 4000 mg/kg bw/day resulted in effects where a NOAEL could not be concluded."
In other words its impossible to overdose. They were feeding these rats massive amounts of high cbd hemp oil and they were perfectly fine. This is a very important consideration in safety profile of an ingredient that can become OTC once farm bill goes through.
Here is a list of institutions dipping their toes into CVSI. With NASDAQ, institutions are about to get crazy.
https://www.nasdaq.com/symbol/cvsi/institutional-holdings
Hilton Capital Mgmt
Panagora Asset Mgmt
Farmers Trust
Davidson & Garrard Inc
Captrust Financial Advisors
Central Trust Co
Alpha Omega Weath Mgmt
Butler Wick Trust Co
Investment Research Corporation
Guaranty Trust Company of Missouri
Please remember, at that Canada was not part of MJ landscape. Now big and retail money has diverted to real multi billion dollars companies. Don't expect similar results from OTC penny stocks counting on previous salami run ups. The MJ run is already happening - look at Canada stocks up 200% to 300%. Hemp run already happening - look at CW*EB and CV*SI.
Btw, where are previous salami plays now. Still pennies. Just waiting for quick run up is gambling on someone's political views without fundamentals to back it.
I agree. It has been pure political analysis bs day after day with catalyst this and catalyst that. Never any analysis on financial aspects, scaling, marketing or fundamental analysis. There are hemp and CBD companies with high growth revenues and net income already exploded 1800% since April and may be exploring options for tie ups with big beverage co for CBD infused drink. Waiting for single political event based P&D without co fundamentals is not stock investing. Research and Invest in CBD companies with products on shelves making money with good brand awareness which will turn out to be real play in CBD drinks.
I noticed that too and thought was a glitch. Is NASDAQ preparing to incorporate CVSI ticker symbol in its main trading?
Your analysis is great but fundamentals hold this one. Farm bill delay and big pharma not letting CBD become dietary or OTC ingredient still a possibility. Do not underestimate billions of dollars of bribery aka lobbying.
I am LT CVSI and strong supporter. Just thought to make sure spammers do not distract CVSI Investor with CAN*. Didn't mean to spam or promote other useless boards.
Thanks for correction on CWEB.
Your calls are very much appreciated. Objective, technical and unbiased. Keep up the good work.